Novonesis to Invest €600 Million in India The Story: Novonesis will invest €600 million to expand its Patalganga site and build an advanced enzyme production facility, expected to be operational by 20...
Dr. Reddy’s Gets Abatacept Biosimilar Approval The Story: Dr. Reddy’s has received CDSCO approval for its abatacept biosimilar in India for rheumatoid arthritis and psoriatic arthritis. The Take: The ...
Mankind Pharma Inks Deal for Two Insulin Analogues The Story: Mankind Pharma has entered an exclusive agreement with Chongqing Chenan to commercialize Insulin Degludec and Insulin Degludec + Aspart in...
Elephas Biosciences, Neuberg Partner on Immuno-therapy Testing The Story: Elephas Biosciences has partnered with Neuberg Diagnostics to bring its elive live-tissue platform to India, with a clinical t...
Key Highlights: Implications: Revahale gives Indian COPD patients—especially older adults and those with severe breathing problems—a simpler, once‑daily nebulized option that doesn’t depend on strong ...
Eisai Launches Leqembi in India for Early Alzheimer’s Disease The Story: Eisai has launched Leqembi (lecanemab) in India after CDSCO approval, introducing the country’s first disease-modifying t...
Summary The Top 10 R&D Spending Indian Biopharma Companies of 2026 reflect the country’s growing commitment to pharmaceutical innovation, advanced drug develop...
The pharmaceutical industry is entering a new era where innovation is no longer driven by individual organisations alone. From drug discovery and clinical research to manufacturing, regulatory complia...
Relevant Market Insights India’s biopharmaceutical sector is at a pivotal point in its evolution. Long celebrated as the world’s “pharmacy of the world” for generics and vaccines, the broader bi...
Latest Developments in Specialty Pharma India’s pharmaceutical industry has built a global reputation as a leading supplier of affordable generic medicines. Over the past two decades, Indian com...